HCPCS Level II · Drugs administered other than oral method
J1932Injection, lanreotide, (cipla), 1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J1932
J1932 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, lanreotide, (cipla), 1 mg.
It was added to HCPCS effective 10/01/2022.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj, lanreotide, (cipla) 1mg
- Date added
- 10/01/2022
- Action effective
- 10/01/2022
- BETOS
- O1E
Related J19xx codes
- J1920Injection, labetalol hydrochloride, 5 mg
- J1921Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
- J1930Injection, lanreotide, 1 mg
- J1931Injection, laronidase, 0.1 mg
- J1938Injection, furosemide, 1 mg
- J1939Injection, bumetanide, 0.5 mg
- J1943Injection, aripiprazole lauroxil, (aristada initio), 1 mg
- J1944Injection, aripiprazole lauroxil, (aristada), 1 mg
- J1946Injection, furosemide (lasix onyu), 1 mg
- J1947Injection, furosemide (furoscix), 1 mg
- J1950Injection, leuprolide acetate (for depot suspension), per 3.75 mg
- J1951Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
Common questions about J1932
Is HCPCS J1932 still valid?
- Yes. J1932 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J1932?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.